Trial document
DRKS00013169
Trial Description
Title
Tattooing suspicious axillary lymph nodes in breast cancer patients treated by primary systemic therapy
Trial Acronym
Tattoo
URL of the Trial
[---]*
Brief Summary in Lay Language
The aim of the study is to investigate the feasibility of tattoing and identifying metastatic axillary lymph nodes in breast cancer patients receiving primary chemotherapy. Up to 74% of these patients of these patients convert to node negative after chemotherapy and in these cases complete axillary dissection is an overtreatment. Sentinel lymph node biopsy in these patients is not accuratly enough and has low detection rates. A previous study in 12 patients has shown a detection of tattowed lymph nodes after primary chemotherapy during surgery in all cases (Choy et al. 2015). This result has to be proved in a larger number of patients. All breast cancer patients treated at the university of Rostock receiving primary chemotherapy without distant metastases can be paticipants of this trial. In these patients higly purifid carbon solution is injected into the suspicious axillary lymphnode, which we hope to find easily during surgery.
Brief Summary in Scientific Language
The aim of the study is to investigate the feasibility of tattoing and identifying metastatic axillary lymph nodes in breast cancer patients receiving primary systemic therapy. Up to 74% of these patients of these patients convert to node negative after chemotherapy and in these cases complete axillary dissection is an overtreatment. SLNB in these patients has unacceptable false-negative rates and clip-marked lymph nodes have low detection rates. A previous study in 12 patients has shown a detection of tattowed lymph nodes after primary systemic therapy during surgery in all cases (Choy et al. 2015).
Amendment 1 18.04.2018: number of patients n=100, multicentric study
Organizational Data
- DRKS00013169
- 2017/10/24
- [---]*
- yes
- Approved
- A 2017-0142, Ethik-Kommission an der Medizinischen Fakultät der Universität Rostock
Secondary IDs
- [---]*
Health Condition or Problem studied
- breast cancer
- C50 - Malignant neoplasm of breast
Interventions/Observational Groups
- 14G-Core needle biopsy and tattoing (highly purified carbon solution: 0,1-0,5ml Spot) of the largest suspicious axillary under ultrasound guidance and documentation prior primary systemic therapy
Characteristics
- Interventional
- [---]*
- Single arm study
- Open (masking not used)
- [---]*
- Uncontrolled/Single arm
- Treatment
- Single (group)
- N/A
- N/A
Primary Outcome
detection rate of charcoal tattoed metastatic axillary lymph nodes during surgery after primary systemic therapy in breast cancer patients
Secondary Outcome
- concordance of SLN and tattooed LN
- predictive value of tattoed LN for residual metastatic disease in other axillary lymph nodes
- complications caused by tattoing axillary lymph nodes (regarding injection until surgery)
Countries of Recruitment
- Germany
- Sweden
Locations of Recruitment
- University Medical Center
Recruitment
- Actual
- 2017/11/07
- 100
- Multicenter trial
- International
Inclusion Criteria
- Female
- 18 Years
- no maximum age
Additional Inclusion Criteria
All patients with primay breast cancer (c/iT1-T4c, uni- or bilateral) diagnosed at the university of Rostock, treated by primary systemic therapy presenting with suspicious axillary lymph nodes (c/i N+) without distant metastases.
Exclusion Criteria
- male patients
- pregnancy
- age < 18 Years
- distant metastases
- no informed consent
Addresses
-
start of 1:1-Block address primary-sponsor
- Universitätsfrauenklinik Rostock
- Südring 81
- 18059 Rostock
- Germany
end of 1:1-Block address primary-sponsorstart of 1:1-Block address contact primary-sponsor- [---]*
- [---]*
- [---]*
- [---]*
end of 1:1-Block address contact primary-sponsor -
start of 1:1-Block address scientific-contact
- Universitätsfrauenklinik Rostock
- Ms. Dr. med. Steffi Hartmann
- Südring 81
- 18059 Rostock
- Germany
end of 1:1-Block address scientific-contactstart of 1:1-Block address contact scientific-contact- 0381/44014500
- [---]*
- steffi.hartmann at kliniksued-rostock.de
- [---]*
end of 1:1-Block address contact scientific-contact -
start of 1:1-Block address public-contact
- Universitätsfrauenklinik
- Ms. Dr. med. Steffi Hartmann
- Südring 81
- 18059 Rostock
- Germany
end of 1:1-Block address public-contactstart of 1:1-Block address contact public-contact- 0381/44014500
- [---]*
- steffi.hartmann at kliniksued-rostock.de
- [---]*
end of 1:1-Block address contact public-contact
Sources of Monetary or Material Support
-
start of 1:1-Block address materialSupport
- Universitätsfrauenklinik Rostock
- Südring 81
- 18059 Rostock
- Germany
end of 1:1-Block address materialSupportstart of 1:1-Block address contact materialSupport- [---]*
- [---]*
- [---]*
- [---]*
end of 1:1-Block address contact materialSupport
Status
- Recruiting complete, follow-up continuing
- [---]*
Trial Publications, Results and other Documents
- [---]*